Jim Tabery, PhD, discusses recent contentions in Utah centered around issues where people feel their personal liberties are being infringed upon by an expanding government, Deseret News, 8 February 2022
In this seminar, Nena Schvaneveldt, discusses how librarians can help with research projects you may have. While librarians are often known as expert literature searchers, they can also help refine...
A Utah doctor took to Twitter to highlight living with a chronic illness during a pandemic, and it’s gone viral. Sarah Bernstein, 35, said she felt conflicted at work as...
Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. We report a bank of human patient-derived xenografts (PDXs) and matched organoid cultures...
This year's Black History Month theme at the U is "Authentically U." What does it mean to be authentic and undisputed? What does it mean to be genuine in everything...
Jim Tabery, PhD, says the public comment period and subsequent amendment may actually be a step in the right direction when it comes to combating misinformation, Deseret News, 25 January...
With an impressive portfolio of impactful science and major awards, and a steady rise in grant funding, fiscal year 2022 is highlighting what we already know: University of Utah Health...
Jim Ruble, PharmD, JD, and core faculty in Center for Health Ethics, Arts, and Humanities (CHeEtAH) discusses overall safety issues around lethal injections .
SFARI is inviting Letters of Intent for its Bridge to Independence Award Program, which engages talented early-career scientists in autism research by facilitating their transition to research independence and providing...
JSMF is encouraging researchers to pursue new questions using conceptual and methodological approaches that take seriously the trajectories, biological and experiential, and contribute to the ongoing development of cognition and...
Health Policy Research Scholars is a leadership opportunity for doctoral students from historically marginalized backgrounds and underrepresented populations across a wide range of disciplines—from economics to political science—who want to...
The Alzheimer’s Drug Discovery Foundation invites Letters of Intent for its Program to Accelerate Clinical Trials. The goal of the program is to support investigational new drug (IND)-enabling studies and...
Johnson & Johnson Innovation LLC and the Healthy Baby Initiative within Janssen Research & Development’s World Without Disease Accelerator in partnership with the Food Allergy Fund, has launched the Food...